DIA has made a strategic investment in Swiss company Odne, which is innovating root canal therapies to enhance patient safety and treatment speed.

Information on the Target

Odne, previously recognized as Lumendo, is a pioneering Swiss company that is transforming the conventional approaches to root canal therapy. This innovative organization has developed a revolutionary root preservation therapy that significantly reduces the need for bleach, allowing endodontic treatments to be executed at a faster pace without compromising patient safety or comfort. By emphasizing minimally invasive techniques, Odne aims to maintain the integrity of tooth structures and enhance long-term treatment outcomes.

With its groundbreaking technology, Odne is setting new standards in dental care. The company has garnered FDA approval for its latest products, which are anticipated to launch in the United States in the first quarter of 2024, creating a promising opportunity for both patients and practitioners in the dental sector.

Industry Overview in Switzerland

The dental industry in Switzerland is characterized by its commitment to innovation and high standards of patient care. As one of Europe’s leading healthcare markets, Switzerland invests h